EDWARD PENHOET
CIK 1198332 · last filed 2019-04-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$452.88M
Companies
7
Total Filings
33
Lifetime Open-Market Net
$482.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | — | $3.80 | — | $0 | 1 | 2015-06-05 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 1 | 2015-01-08 |
| CCXI | Director | 114,910 | $10.32 | $1.19M | $0 | 3 | 2013-05-24 |
| ZYMOGENETICS INC (ZGEN) Delisted | Director | 0 | $12.01 | $0 | $0 | 6 | 2010-10-12 |
| CORT | Director | 5,525,313 | $81.75 | $451.69M | $482.5K | 5 | 2010-04-06 |
| IDM PHARMA, INC. (IDMI) Delisted | Director | 1,829 | — | — | $0 | 4 | 2008-06-26 |
| RENOVIS INC (RNVS) Delisted | Director | 79,028 | — | — | $0 | 2 | 2007-05-16 |
Recent Filings · Page 2 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-01-08 | — | Grant (A) | — | $0 | |
| 2013-11-01 | — | Grant (A) | — | $0 | |
| 2013-05-24 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-06-26 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-02-15 | CCXI | Conv (C) | +1,868,088 | $0 | EDGAR |
| 2010-10-12 | ZYMOGENETICS INC (ZGEN) Delisted | U | −72,000 | -$702.0K | EDGAR |
| 2010-08-19 | ZYMOGENETICS INC (ZGEN) Delisted | Exer (M) | +72,000 | $200.0K | EDGAR |
| 2010-06-18 | ZYMOGENETICS INC (ZGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-04-06 | CORT | Exer (M) | +41,250 | $72.9K | EDGAR |
| 2009-10-20 | CORT | Buy (P) | +349,651 | $482.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.